Rolofylline fails in acute CHF

Links shared publicly online about this topic.

  • 1,780
    total visits

Rolofylline fails in acute CHF

theheart.org

The adenosine antagonist was no more effective than placebo in the treatment of acute heart failure and was also associated with a higher incidence of stroke and seizure in the PROTECT trial.

View full resource at theheart.org

Tags: Heart, Heart Disease, Heart Failure, Seizure, Stroke, Thrombotic Event

  • Share

Most Recently Shared on September 1, 2009 at 5:23 pm By:

theheartorg Shelley Wood

heartwire: Rolofylline fails to PROTECT in acute heart failure http://bit.ly/2jB9uN #ESC09

3 years ago...

Novel Diuretic Enhancer Fails in Acute HF (CME/CE) - QualityPoint Technologies

qualitypointtech.net — “(MedPage Today) -- The novel adenosine antagonist rolofylline failed to improve outcomes for acute heart failure patients with impaired renal function, bringing the whole class down with it.View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on October 7, 2010 at 1:48 pm By:

MedicalFeed MedicalFeed Health News Feed

Novel Diuretic Enhancer Fails in Acute HF (CME/CE): (MedPage Today) -- The novel adenosine antagonist rolofylline ... http://bit.ly/b6YLFv

2 years ago...

Medical News: Novel Diuretic Enhancer Fails in Acute HF - in Cardiovascular, CHF from MedPage Today

medpagetoday.com — “The novel adenosine antagonist rolofylline failed to improve outcomes for acute heart failure patients with impaired renal function, bringing the whole class down with it.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on October 7, 2010 at 1:34 pm By:

PattyGrace Patricia Grace Eldercare Expert

Novel Diuretic Enhancer Fails in Acute HF (CME/CE): (MedPage Today) -- The novel adenosine antagonist rolofylline ... http://bit.ly/cjCpP0

2 years ago...

Once-Promising Heart Failure Drug Fails in Trial - Health News - Health.com

news.health.com — “By Amanda GardnerHealthDay ReporterWEDNESDAY, Oct. 6 (HealthDay News) — A new experimental drug for treating patients who have acute heart failure plus kidney failure did not show any overall benefit, indicating that the future of this particular drug, called rolofylline, is over.“I think this is the end of the story for this drug,” said Dr. [...]View full resource at news.health.com

  • View Related
  • Share

Most Recently Shared on October 6, 2010 at 11:45 pm By:

lsaldanamd Luis Saldana Emergency Physician, Physician, and Doctor

Once-Promising Heart Failure Drug Fails in Trial (http://bit.ly/aohfga) - Health.com | @SkyGrid

2 years ago...

Advertisement